Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
about
The enemy within: intronic miR-26b represses its host gene, ctdsp2, to regulate neurogenesisMicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7miRNAs in human cancerThe role of miR-26 in tumors and normal tissues (Review)An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastomaRecent advances in the molecular understanding of glioblastomaMicroRNA-182-5p targets a network of genes involved in DNA repairmiRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarksExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsMicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneThe roles of PIKE in tumorigenesisPathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancerThe future role of personalized medicine in the treatment of glioblastoma multiformeMicroRNAs: history, biogenesis, and their evolving role in animal development and diseaseBreakthroughs in genomics data integration for predicting clinical outcomeThe elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?The role of microRNAs in glioma initiation and progression.Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survivalIdentifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataIdentification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex DiseaseMicroRNA and target protein patterns reveal physiopathological features of glioma subtypes.Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.PTEN Tumor Suppressor Network in PI3K-Akt Pathway ControlGenome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.MicroRNAs in human cancer.Mature miRNAs form secondary structure, which suggests their function beyond RISC.The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivoThe loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.Hydrogen sulfide accelerates cell cycle progression in oral squamous cell carcinoma cell lines.A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy.Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.Simultaneous detection of 19 K-ras mutations by free-solution conjugate electrophoresis of ligase detection reaction products on glass microchips.The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignanciesClinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtypemicroRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma.
P2860
Q24608404-9BCB916C-7039-49F3-BFA2-B084A51CEAA8Q24621432-7E9B4EA7-B0BB-4505-BE7E-B148A35A836FQ24628889-3C944787-6B46-4A54-AD38-657721E48086Q24629056-AE6A64A4-2288-48A9-B36F-1C22EE1709E6Q24629145-E6BE1AA4-90F0-4FC7-BFA1-64942DB5870DQ24632928-A413B9BD-C3C0-417D-8F78-F48C6651AB7AQ24633326-A4307D24-F876-4D77-B468-9A760FFD6C02Q26781836-A81A2BA3-28DD-4325-A003-985EFE344807Q26796590-58CC6C90-DF2C-45E0-9ECB-FF3EECE9F904Q27013740-22D2FDAC-57EF-4A57-9354-84EF37EA30B9Q27023876-33F012E4-CDF7-469F-8470-506C35AF53C2Q28295895-37308E6E-C6AD-445E-B8F2-E1BF166B2B42Q28391635-4F740A64-16A4-43B7-A9F0-E1BEC0677049Q28657834-9392D5BC-9B30-4EF9-BEBB-8E6498293C9EQ28708853-00AFDEBD-A6A8-4562-BED7-DFEBC59F4597Q30426792-9F1345AA-CC10-4A1D-80D7-CFC07E10FC5BQ30428370-D35725A9-200C-4718-A25F-7660BBA583C5Q30495169-9F5F7042-27DF-48DA-B1A9-D34B04BEE4E3Q30587051-7A443306-F77C-45CE-AEF9-71A417D823E6Q30763468-3AF98D9E-B4E2-4849-8EDA-BA100309D8B1Q33871743-411F7D95-BC24-43D8-877E-3A8FC0A28A9DQ33877366-E12E09B6-ECEC-4B3A-89D7-0F49E217E6DBQ33926927-68A92E69-D324-4542-8461-F1E9AE823338Q33948651-4CA0B2B7-8FDB-424F-80F2-E9F565C8ECA5Q34002594-F2F164AF-BE18-4DA8-8D07-E55690A440D6Q34202681-877AF300-3B8A-463D-93D5-95ABA716FCFFQ34257360-454BDEC0-467B-4546-B953-FAC62F7DEB32Q34325959-A89F97DF-798B-41D7-BBD4-DB61E4A2280DQ34572186-3602342A-0C53-4026-AC75-469B5A84518BQ34936837-2119D08B-5C49-4184-B715-1DD5F0329B12Q35014682-D6B995E4-BF41-40EC-AE83-5AFC6FE7E6E2Q35032496-242C1EC5-54F1-45EC-AAA2-EDE26C1D3670Q35066321-3E3E1E88-2BC8-4CD6-B1C6-6B120CD7AF17Q35109557-5F46AB11-5939-485D-A957-7700DAA08A47Q35123099-98604F1B-8AD3-49D5-8184-3E4900FD5E4DQ35156742-3E560880-DD03-43AF-9A79-C2E288D4FFFEQ35180764-CB4FAF16-7C3A-466A-9F33-3AF11B211B41Q35235849-59EF7EF9-63B0-4D79-93B7-E2122077D610Q35634253-EE1F6027-D324-4EB5-9231-21D98DF280BAQ35684366-2E64679F-A91E-436D-B144-F5A9ABD67909
P2860
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Integrative genome analysis re ...... ing glioblastoma survivorship.
@ast
Integrative genome analysis re ...... ing glioblastoma survivorship.
@en
type
label
Integrative genome analysis re ...... ing glioblastoma survivorship.
@ast
Integrative genome analysis re ...... ing glioblastoma survivorship.
@en
prefLabel
Integrative genome analysis re ...... ing glioblastoma survivorship.
@ast
Integrative genome analysis re ...... ing glioblastoma survivorship.
@en
P2093
P2860
P356
P1476
Integrative genome analysis re ...... ing glioblastoma survivorship.
@en
P2093
Brenton Pennicooke
Hyunsoo Kim
Mark D Johnson
Peter J Park
Xiuli Jiang
P2860
P304
P356
10.1073/PNAS.0909896107
P407
P577
2010-01-13T00:00:00Z